ÖZKAN, E. Et Al. 2012. The Additive Clinical Value of F-18-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels. CLINICAL NUCLEAR MEDICINE , vol.37, no.8 , 755-758.

ÖZKAN, E., SOYDAL, Ç., ARAZ, M., Aras, G., & İBİŞ, E., (2012). The Additive Clinical Value of F-18-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels. CLINICAL NUCLEAR MEDICINE , vol.37, no.8, 755-758.

ÖZKAN, ELGİN Et Al. "The Additive Clinical Value of F-18-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels," CLINICAL NUCLEAR MEDICINE , vol.37, no.8, 755-758, 2012

ÖZKAN, ELGİN Et Al. "The Additive Clinical Value of F-18-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels." CLINICAL NUCLEAR MEDICINE , vol.37, no.8, pp.755-758, 2012

ÖZKAN, E. Et Al. (2012) . "The Additive Clinical Value of F-18-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels." CLINICAL NUCLEAR MEDICINE , vol.37, no.8, pp.755-758.

@article{article, author={ELGİN ÖZKAN Et Al. }, title={The Additive Clinical Value of F-18-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels}, journal={CLINICAL NUCLEAR MEDICINE}, year=2012, pages={755-758} }